Lack of Toll IL-1R8 Exacerbates Th17 Cell Responses in Fungal Infection
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
TLRs contribute to the inflammatory response in fungal infections. Although inflammation is an essential component of the protective response to fungi, its dysregulation may significantly worsen fungal diseases. In this study, we tested the hypothesis that Toll IL-1R8 (TIR8)/single Ig IL-1-related receptor, a member of the IL-1R family acting as a negative regulator of TLR/IL-1R signaling, affects TLR responses in fungal infections. Genetically engineered Tir8−/− mice were assessed for inflammatory and adaptive Th cell responses to Candida albicans and Aspergillus fumigatus. Inflammatory pathology and susceptibility to infection were higher in Tir8−/− mice and were causally linked to the activation of the Th17 pathway. IL-1R signaling was involved in Th17 cell activation by IL-6 and TGF-β in that limited inflammatory pathology and relative absence of Th17 cell activation were observed in IL-1RI−/− mice. These data demonstrate that TIR8 is required for host resistance to fungal infections and that it functions to negatively regulate IL-1-dependent activation of inflammatory Th17 responses. TIR8 may contribute toward fine-tuning the balance between protective immunity and immunopathology in infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Veldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M., & Stockinger, B. (2006) · Immunity · doi:10.1016/j.immuni.2006.01.001 · Cited by 3,605
Phenotypic and functional features of human Th17 cells
Annunziato, F., Cosmi, L., Santarlasci, V., Maggi, L., Liotta, F., Mazzinghi, B., Parente, E., Filì, L., Ferri, S., Frosali, F., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070663 · Cited by 1,861 · cited 2×
“Given the crucial role for IL-1 in the induction of IL-17-producing T cells (14, 35, 36), we assessed in this study whether IL-1 could contribute to the ability of Candidapulsed DCs to prime CD4 CD62L naive cells for IL-17 production and Rorc mRNA expression in vitro in condition of TIR8 deficiency.”
BackgroundAcosta-Rodriguez, E. V., Napolitani, G., Lanzavecchia, A., & Sallusto, F. (2007) · Nature Immunology · doi:10.1038/ni1496 · Cited by 1,857 · cited 3×
“Given the crucial role for IL-1 in the induction of IL-17-producing T cells (14, 35, 36), we assessed in this study whether IL-1 could contribute to the ability of Candidapulsed DCs to prime CD4 CD62L naive cells for IL-17 production and Rorc mRNA expression in vitro in condition of TIR8 deficiency.”
BackgroundRegulation of immune responses by L-arginine metabolism
Bronte, V., & Zanovello, P. (2005) · Nature Reviews Immunology · doi:10.1038/nri1668 · Cited by 1,775 · cited 1×
“Therefore, PMNs from Tir8 / mice have reduced antifungal effector functions and showed signatures of alternatively activated phagocytes (4, 27).”
BackgroundNegative regulation of Toll-like receptor-mediated immune responses
Liew, F. Y., Xu, D., Brint, E. K., & O'Neill, L. A. J. (2005) · Nature Reviews Immunology · doi:10.1038/nri1630 · Cited by 1,509 · cited 3×
“In this regard, TLR activation is a double-edged sword, and negative regulation of TLR signaling may be required to avoid detrimental and inappropriate inflammatory responses (2, 3), because the immune system needs to constantly balance activation by TLR signaling and inhibition by negative regulators.”
BackgroundLeibundGut-Landmann, S., Groß, O., Robinson, M. J., Osorio, F., Slack, E. C., Tsoni, S. V., Schweighoffer, E., Tybulewicz, V., Brown, G. D., Ruland, J., et al. (2007) · Nature Immunology · doi:10.1038/ni1460 · Cited by 1,191 · cited 1×
“Recent studies have shown that the Th17 pathway is activated by Candida albicans (14, 15), acts as a negative regulator of the Th1-mediated immune resistance to both C.”
BackgroundRequirement of Interleukin‐17A for Systemic Anti– Candida albicans Host Defense in Mice
Huang, W., Na, L., Fidel, P. L., & Schwarzenberger, P. (2004) · The Journal of Infectious Diseases · doi:10.1086/422329 · Cited by 859 · cited 2×
“TIR8 is known to act as a decoy receptor for the formation of a signaling complex, which subsequently inhibits IL-1 and TLR4 signaling through NF- B activation, and thereby fine-tunes IL-1or TLR4-dependent inflammatory responses (4, 6, 33).”
BackgroundCutting Edge: Interleukin 17 Signals through a Heteromeric Receptor Complex
Toy, D., Kugler, D., Wolfson, M., Bos, T. V., Gurgel, J., Derry, J., Tocker, J., & Peschon, J. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.1.36 · Cited by 570 · cited 2×
“However, because susceptibility to disseminated candidiasis is increased in IL-17AR-deficient mice (33), it is likely that the biological activity of IL-17 cannot be attributed solely to the presence and activation of IL-17AR, as suggested (34).”
BackgroundBellocchio, S., Montagnoli, C., Bozza, S., Gaziano, R., Rossi, G., Mambula, S. S., Vecchi, A., Mantovani, A., Levitz, S. M., & Romani, L. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.5.3059 · Cited by 515
Self-citationEriksson, U., Kurrer, M. O., Sonderegger, I., Iezzi, G., Tafuri, A., Hunziker, L., Suzuki, S., Bachmaier, K., Bingisser, R. M., Penninger, J. M., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021788 · Cited by 158 · cited 1×
“immune T cell activation (14, 35, 36, 40, 41) has been extensively”
Background
Cited by
The interleukin-1 family: back to the future
Garlanda, C., Dinarello, C. A., & Mantovani, A. (2013) · Immunity · doi:10.1016/j.immuni.2013.11.010 · Cited by 1,945
“aeruginosa infection (Bozza et al., 2008; Chen et al., 2011; Garlanda et al., 2007a; Huang et al., 2006).”
The IL-1 family: regulators of immunity
Sims, J. E., & Smith, D. E. (2010) · Nature Reviews Immunology · doi:10.1038/nri2691 · Cited by 1,418
Conti, H. R., Shen, F., Nayyar, N., Stocum, E., Sun, J. N., Lindemann, M. J., Ho, A. W., Hai, J. H., Yu, J. J., Jung, J. W., et al. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20081463 · Cited by 1,024
Interleukin‐17 in host defence against bacterial, mycobacterial and fungal pathogens
Curtis, M. M., & Way, S. S. (2009) · Immunology · doi:10.1111/j.1365-2567.2008.03017.x · Cited by 502
Nold-Petry, C. A., Lo, C. Y., Rudloff, I., Elgass, K. D., Li, S., Gantier, M. P., Lotz-Havla, A. S., Gersting, S. W., Cho, S. X., Lao, J. C., et al. (2015) · Nature Immunology · doi:10.1038/ni.3103 · Cited by 439
Self-citationRequisite Role for the Dectin-1 β-Glucan Receptor in Pulmonary Defense against Aspergillus fumigatus
Werner, J. L., Metz, A. E., Horn, D., Schoeb, T. R., Hewitt, M. M., Schwiebert, L. M., Faro-Trindade, I., Brown, G. D., & Steele, C. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0804250 · Cited by 412
Myeloid C-type Lectin Receptors in Pathogen Recognition and Host Defense
Osorio, F., & Reis e Sousa, C. (2011) · Immunity · doi:10.1016/j.immuni.2011.05.001 · Cited by 378
Interleukin-17 and innate immunity in infections and chronic inflammation
Isailovic, N., Daigo, K., Mantovani, A., & Selmi, C. (2015) · Journal of Autoimmunity · doi:10.1016/j.jaut.2015.04.006 · Cited by 363
Self-citationIL-22 defines a novel immune pathway of antifungal resistance
De Luca, A., Zelante, T., D'Angelo, C., Zagarella, S., Fallarino, F., Spreca, A., Iannitti, R. G., Bonifazi, P., Renauld, J.-C., Bistoni, F., et al. (2010) · Mucosal Immunology · doi:10.1038/mi.2010.22 · Cited by 265
Self-citationPrecarious Balance: Th17 Cells in Host Defense
Peck, A., & Mellins, E. D. (2010) · Infection and Immunity · doi:10.1128/iai.00929-09 · Cited by 236
“Such bias results in tissue injury and reduced fungal clearance, in part by impairing the killing activity while extending the viability of recruited neutrophils (8, 102).”
BackgroundGulen, M. F., Kang, Z., Bulek, K., Youzhong, W., Kim, T. W., Chen, Y., Altuntas, C. Z., Sass Bak-Jensen, K., McGeachy, M. J., Do, J.-S., et al. (2010) · Immunity · doi:10.1016/j.immuni.2009.12.003 · Cited by 199
“In addition to the role of SIGIRR in mucosal immunity (Garlanda et al., 2004; Xiao et al., 2007), recent studies have shown the critical role of SIGIRR in modulating autoimmunity and inflammatory responses associated with infections (Bozza et al., 2008; Garlanda et al., 2007).”
BackgroundResultDirecting traffic: IL‐17 and IL‐22 coordinate pulmonary immune defense
McAleer, J. P., & Kolls, J. K. (2014) · Immunological Reviews · doi:10.1111/imr.12183 · Cited by 194
“For instance, Toll IL-1R8 reduces inflammatory pathology and IL-17 levels following pulmonary fungal infection by inhibiting IL-1R signaling (26).”
BackgroundThe Multifaceted Role of T-Helper Responses in Host Defense against Aspergillus fumigatus
Dewi, I., Van de Veerdonk, F., & Gresnigt, M. (2017) · Journal of Fungi · doi:10.3390/jof3040055 · Cited by 69
“Tir8−/− mice were more susceptible to infection and exhibited a higher inflammatory pathology; this finding highlighted the possible role of TIR8 in orchestrating protective response or immunopathology against fungal infection [68].”
BackgroundChoteau, L., Vancraeyneste, H., Le Roy, D., Dubuquoy, L., Romani, L., Jouault, T., Poulain, D., Sendid, B., Calandra, T., Roger, T., et al. (2017) · Gut Pathogens · doi:10.1186/s13099-017-0158-0 · Cited by 59
Self-citation
Metadata
- Authors
- Bozza, S., Zelante, T., Moretti, S., Bonifazi, P., DeLuca, A., D’Angelo, C., Giovannini, G., Garlanda, C., Boon, L., Bistoni, F., Puccetti, P., Mantovani, A., & Romani, L.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-03
- Volume
- 180
- Issue
- 6
- Pages
- 4022-4031
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1646256271
- Cited by
- 122
- References
- 10
- FWCI
- 6.42
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.